Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
PHARMACEUTICAL COMPOSITION CONTAINING DEMETHYLZEYLASTERAL FOR PREVENTION OR TREATMENT OF DISEASES CAUSED BY MUSCLE LOSS
Document Type and Number:
WIPO Patent Application WO/2023/249354
Kind Code:
A1
Abstract:
A composition containing demethylzeylasteral or a pharmaceutically acceptable salt thereof, according to the present invention, is highly effective at promoting muscle differentiation and inhibiting muscle degradation, as a glucocorticoid receptor antagonist that inhibits intracellular activity of the glucocorticoid receptor, in order to prevent or treat diseases caused by muscle loss.

Inventors:
YANG HEE (KR)
SHIN SEO HYUN (KR)
YANG SEUNG HEE (KR)
KIM NA RA (KR)
YOON JUNG HAN (KR)
LEE KI WON (KR)
Application Number:
PCT/KR2023/008463
Publication Date:
December 28, 2023
Filing Date:
June 19, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SEOUL NAT UNIV R&DB FOUNDATION (KR)
International Classes:
A61K31/19; A23K20/105; A23L33/10; A61P21/00
Domestic Patent References:
WO2017070615A12017-04-27
Foreign References:
US20110218143A12011-09-08
Other References:
ZHAO YUZU, HE JIANG, LI JUN, PENG XINGZHI, WANG XIANXING, DONG ZHEN, ZHAO ERHU, LIU YALING, WU ZONGHUI, CUI HONGJUAN: "Demethylzeylasteral inhibits cell proliferation and induces apoptosis through suppressing MCL1 in melanoma cells", CELL DEATH & DISEASE, NATURE PUBLISHING GROUP, GB, vol. 8, no. 10, GB , pages e3133 - e3133, XP093119237, ISSN: 2041-4889, DOI: 10.1038/cddis.2017.529
ZHANG KUI, FU GANG, PAN GUANGZHAO, LI CHONGYANG, SHEN LI, HU RENJIAN, ZHU SHUNQIN, CHEN YIBIAO, CUI HONGJUAN: "Demethylzeylasteral inhibits glioma growth by regulating the miR-30e-5p/MYBL2 axis", CELL DEATH & DISEASE, NATURE PUBLISHING GROUP, GB, vol. 9, no. 10, GB , XP093119238, ISSN: 2041-4889, DOI: 10.1038/s41419-018-1086-8
LI LIU; JI YI; FAN JUNTING; LI FURONG; LI YAN; WU MIANHUA; CHENG HAIBO; XU CHANGLIANG: "Demethylzeylasteral (T-96) inhibits triple-negative breast cancer invasion by blocking the canonical and non-canonical TGF-β signaling pathways", NAUNYN-SCHMIEDEBERG'S ARCHIVES OF PHARMACOLOGY, SPRINGER, DE, vol. 392, no. 5, 6 February 2019 (2019-02-06), DE , pages 593 - 603, XP036754296, ISSN: 0028-1298, DOI: 10.1007/s00210-019-01614-5
Attorney, Agent or Firm:
LEECHAE INTELLECTUAL PROPERTY (KR)
Download PDF: